XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.2
Revenue and Contract Acquisition Costs
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue and Contract Acquisition Costs Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended June 30,Six Months Ended June 30,
(in millions)2025202420252024
U.S.
$453.2 $352.3 $854.9 $670.0 
International
185.8 128.2 338.1 243.4 
Total Omnipod products
639.0 480.4 1,193.0 913.4 
Drug Delivery10.2 8.1 25.1 16.8 
Total revenue$649.1 $488.5 $1,218.1 $930.2 
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended June 30,Six Months Ended June 30,

2025202420252024
Distributor A26 %29 %26 %27 %
Distributor B27 %22 %25 %26 %
Distributor C
22 %23 %23 %22 %
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
June 30, 2025December 31, 2024
Accrued expenses and other current liabilities$17.4 $12.0 
Other liabilities1.4 2.0 
Total deferred revenue$18.7 $14.0 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Three Months Ended June 30,Six Months Ended June 30,
(in millions)2025202420252024
Deferred revenue recognized$0.5 $4.0 $6.2 $7.2 
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)June 30, 2025December 31, 2024
Prepaid expenses and other current assets$22.6 $20.1 
Other assets46.3 40.8 
Total capitalized contract acquisition costs, net$69.0 $60.9 
The Company recognized $5.5 million and $4.4 million of amortization of capitalized contract acquisition costs during the three months ended June 30, 2025 and 2024, respectively, and recognized $10.6 million and $8.6 million of amortization of capitalized contract acquisition costs during the six months ended June 30, 2025 and 2024, respectively.